Ashton Jones (Football Recruiting, 2025)
Story Poster
TexAgs' TXHSFB Recap: Reviewing our coverage from the Bi-District round
1 mo ago by TexAgs Recruiting
The playoffs are officially underway in the state of Texas as the march to AT&T Stadium begins to heat up. It's time to look back at the TXHSFB highlights that Jason Howell, Ryan Brauninger and Cade Draughon saw during the bi-district round of the playoffs.
Story Poster
2:32
Highlights: Fort Bend Elkins pulls off first-round upset of Shadow Creek
1 mo ago by Cade Draughon
On the first night of the playoffs, Fort Bend Elkins pulled off an incredible upset against one of the most talent-rich teams in the Houston area with a 31-28 win over Shadow Creek at Freedom Field. TexAgs was there to catch the action and now presents the highlights.
Story Poster
3:08
Highlights: Shadow Creek gets into the win column vs. Clear Creek
3 mo ago by Cade Draughon
Shadow Creek got back into the win column after a Week 1 loss with a dominating 34-7 win over Clear Creek, as there was plenty of talent on the field, and the Sharks showed flashes of talent on both sides of the ball. TexAgs was there and now presents the highlights.
Get access to all Premium content today
Start your subscription for just $1
Try Premium Now
Author
Visitor List: Texas A&M vs McNeese
3 mo ago by Ryan Brauninger
Story Poster
Around Texas: A round-up of recruiting news in the Lone Star State
11 mo ago by Jason Howell
The calendar has turned from 2023 to 2024 as the February signing period is quickly approaching. It is time to take a look at the latest happenings in the Lone Star state and SEC footprint on the recruiting front.
Story Poster
2:37
Highlights: Shadow Creek outlasts Manvel in Friday night opener
1 yr ago by Cade Draughon
Shadow Creek started the 2023 season on a roll in Week 1 with a non-conference runaway road win over Manvel, 34-15. TexAgs brings you the highlights of the Friday night action.
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.